Friday, September 13, 2013The High Blood Pressure Research Scientific Sessions 2013 is one of the most important medical meetings on high blood pressure in the world. It includes pre-conference meetings, workshops, lectures on cutting edge research, awards for excellence for late and early career investigators, and oral and poster presentations selected from submissions by clinical and basic researchers from over 20 countries. View program.
SCIENCE NEWS coverage includes video interviews with council and program chairs, awards finalists and winners, and keynote lecturers as well as selected science and statistics related to the topics presented each day of the meeting.
Friday’s SCIENCE NEWS coverage includes video interviews with a number of award winning investigators who will discuss the significance of their work for clinical practice and patient care.
- Relative Atrial Natriuretic Peptide Deficiency and Inadequate Renin and Angiotensin II Suppression in Obese Hypertensive Men
- Aldosterone & Cardiometabolic Risk Factors: Abnormal Aldosterone Physiology and Cardiometabolic Risk Factors
- Substantial Reduction in Single Sympathetic Nerve Firing After Renal Denervation in Patients With Resistant Hypertension
- Translational Examination of Changes in Baroreflex Function After Renal Denervation in Hypertensive Rats and Humans
- Sympathoexcitation by Brain Oxidative Stress Mediates Arterial Pressure Elevation in Salt-Induced Chronic Kidney Disease
Circulation. 2013;127:21-23, published online before print December 13 2012, doi:10.1161/CIRCULATIONAHA.112.155911
- In 2008, the prevalence of end-stage renal disease was almost 548,000 with over 112,000 new cases being reported.
- The USRDS estimates that by 2020, more than 700,000 Americans will have end-stage renal disease.
- Nearly 26 million people (13%) in the United States have chronic kidney disease, and most are undiagnosed. Another 20 million are at increased risk for chronic kidney disease.